Login / Signup

PBP-3 Directed Therapy in VIM-producing Pseudomonas aeruginosa Creates Bacterial Transformers, Persisters in Disguise.

Nicholas M SmithKatie Rose BoissonneaultPatricia N HoldenJan Naseer KaurJack F KlemRaymond ChaMark D SuttonBrian T Tsuji
Published in: International journal of antimicrobial agents (2024)
Managing MBL-producing P. aeruginosa requires a multifaceted approach, focused on maximising killing and minimising proliferation of resistant and persistent subpopulations, which will involve eliminating drug-induced phenotypic transformers.
Keyphrases
  • drug induced
  • liver injury
  • pseudomonas aeruginosa
  • cystic fibrosis
  • signaling pathway
  • biofilm formation
  • adverse drug
  • escherichia coli
  • mesenchymal stem cells
  • bone marrow
  • electronic health record
  • smoking cessation